Daily vs Intermittent Iron Therapy in Pregnancy

Completed · Not applicable

Conditions studied: Iron Deficiency Anemia of Pregnancy

In brief

This is a randomized non inferiority trial to evaluate the response to iron therapy in the standard daily vs. intermittent (three-four times a week on nonconsecutive days) groups by using hematological markers (hemoglobin, hematocrit, transferrin, hepcidin, ferritin, human soluble transferrin receptor). The secondary outcome is to evaluate gastrointestinal discomfort and adherence to therapy between two treatment groups.

Key facts

Study ID
NCT03706638
Run by
UConn Health
People needed
46
Starts
2018-10-25
Expected to finish
2020-03-23
Last updated by the study team
2020-04-21

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.